Back
Invesco High Yield Eq Div Achiev™ ETF Vs. NovoCure Industry Stock Comparison
Sell
45
PEY
Invesco High Yield Eq Div Achiev™ ETF
Last Price:
22.12
Seasonality Move:
-1.78%
Buy
75
NVCR
NovoCure
Last Price:
33.40
Seasonality Move:
-5.24%
Sell
45
Invesco High Yield Eq Div Achiev™ ETF (PEY)
is a Sell
Is Invesco High Yield Eq Div Achiev™ ETF a Buy, Sell or Hold?
- The current Invesco High Yield Eq Div Achiev™ ETF [PEY] share price is $22.13. The Score for PEY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- PEY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
NovoCure (NVCR)
is a Buy
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $33.41. The Score for NVCR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PEY Stock Price Chart
What is Invesco High Yield Eq Div Achiev™ ETF's stock price today?
-
The Invesco High Yield Eq Div Achiev™ ETF share price today is $22.13
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PEY is experiencing buying pressure, which is a positive indicator for future bullish movement.
PEY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 44.85 | Sell |
| Chaikin Money Flow: | 186769 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.07 - 22.73) | Sell |
| Bollinger Bands (100): | (21.2 - 22.28) | Buy |
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.78 | Buy |
| Relative Strength Index (14 RSI): | 75.34 | Buy |
| Chaikin Money Flow: | 1118573 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.36 - 28.56) | Buy |
| Bollinger Bands (100): | (14.7 - 22.78) | Buy |
PEY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.3 | Sell |
| 20-day SMA: | 22.47 | Sell |
| 50-day SMA: | 22.1 | Buy |
| 200-day SMA: | 20.89 | Buy |
| 8-day EMA: | 22.29 | Sell |
| 20-day EMA: | 22.35 | Sell |
| 50-day EMA: | 22.12 | Buy |
| 200-day EMA: | 21.18 | Buy |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.6 | Buy |
| 20-day SMA: | 23.68 | Buy |
| 50-day SMA: | 19.33 | Buy |
| 200-day SMA: | 17.9 | Buy |
| 8-day EMA: | 29.53 | Buy |
| 20-day EMA: | 25.45 | Buy |
| 50-day EMA: | 21.38 | Buy |
| 200-day EMA: | 19.88 | Buy |
Invesco High Yield Eq Div Achiev™ ETF Earnings Growth & PEY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.31 per share.
Invesco High Yield Eq Div Achiev™ ETF Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovoCure Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||